First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of First Tracks Biotherapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. First Tracks Biotherapeutics Inc. market cap is $1.45B.
What is the 52-week high for First Tracks Biotherapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. First Tracks Biotherapeutics Inc. 52 week high is $49.91 as of September 05, 2026.
What is the 52-week low for First Tracks Biotherapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. First Tracks Biotherapeutics Inc. 52 week low is $14.72 as of September 05, 2026.
What is First Tracks Biotherapeutics Inc. stock price today?
First Tracks Biotherapeutics Inc. stock price today is $40.46.
What was First Tracks Biotherapeutics Inc. stock price yesterday?
First Tracks Biotherapeutics Inc. stock price yesterday was $42.51.
What is the Price-to-Book ratio of First Tracks Biotherapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. First Tracks Biotherapeutics Inc. P/B ratio is 8.4831.
What is the 50-day moving average of First Tracks Biotherapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. First Tracks Biotherapeutics Inc. 50-day moving average is $38.17.